Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

An association study of functional polymorphic genes IRF-1, IFNGR-1, and IFN-γ with disease progression, aspartate aminotransferase, alanine aminotransferase, and viral load in chronic hepatitis B and C.

Korachi M, Ceran N, Adaleti R, Nigdelioglu A, Sökmen M.

Int J Infect Dis. 2013 Jan;17(1):e44-9. doi: 10.1016/j.ijid.2012.08.004. Epub 2012 Oct 3.

2.

Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection.

Cheong JY, Cho SW, Chung SG, Lee JA, Yeo M, Wang HJ, Lee JE, Hahm KB, Kim JH.

Biochem Genet. 2006 Jun;44(5-6):246-55. Epub 2006 Aug 30.

PMID:
16944293
4.

Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations.

Watanabe K, Takahashi T, Takahashi S, Okoshi S, Ichida T, Aoyagi Y.

J Gastroenterol Hepatol. 2005 Mar;20(3):441-9.

PMID:
15740490
5.

Association of polymorphisms in interleukin-18 and interleukin-28B with hepatitis B recurrence after liver transplantation in Chinese Han population.

Li Y, Shi Y, Chen J, Cai B, Ying B, Wang L.

Int J Immunogenet. 2012 Aug;39(4):346-52. doi: 10.1111/j.1744-313X.2012.01097.x. Epub 2012 Feb 10.

PMID:
22325058
7.

HLA-DP and γ-interferon receptor-2 gene variants and their association with viral hepatitis activity in chronic hepatitis B infection.

Lam YF, Wong DK, Seto WK, To KK, Hung IF, Fung J, Lai CL, Yuen MF.

J Gastroenterol Hepatol. 2014 Mar;29(3):533-9. doi: 10.1111/jgh.12378.

PMID:
23980639
8.

Hepatitis B viraemia: its heritability and association with common genetic variation in the interferon gamma signalling pathway.

Huang HH, Shih WL, Li YH, Wu CF, Chen PJ, Lin CL, Liu CJ, Liaw YF, Lin SM, Lee SD, Yu MW.

Gut. 2011 Jan;60(1):99-107. doi: 10.1136/gut.2010.207670. Epub 2010 Oct 27.

PMID:
20980339
9.

[Association between IFN-gamma+874 polymorphisms and the clinical outcomes of hepatitis B and/or hepatitis C virus infection.].

Gao QJ, Liu DW, Zhang SY, Jia M, Wu LH.

Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Mar;31(3):324-8. Chinese.

PMID:
20510064
10.

Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.

Wietzke-Braun P, Maouzi AB, Mänhardt LB, Bickeböller H, Ramadori G, Mihm S.

Eur J Gastroenterol Hepatol. 2006 Sep;18(9):991-7.

PMID:
16894313
11.

Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.

Kaya S, Cetin ES, Aridogan BC, Arikan S, Demirci M.

J Microbiol Immunol Infect. 2007 Aug;40(4):288-92.

PMID:
17712462
12.

Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.

Lee MH, Kim YM, Kim SG.

Int J Clin Pharmacol Ther. 2012 Nov;50(11):778-86. doi: 10.5414/CP201746.

PMID:
22943930
13.

Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection.

Yoshioka K, Ito H, Watanabe K, Yano M, Ishigami M, Mizutani T, Sasaki Y, Goto H.

J Viral Hepat. 2005 Mar;12(2):139-45.

PMID:
15720528
14.

Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.

Abbate I, Romano M, Longo R, Cappiello G, Lo Iacono O, Di Marco V, Paparella C, Spano A, Capobianchi MR.

J Med Virol. 2003 Aug;70(4):581-7.

PMID:
12794720
15.

Toll-like receptor 3 gene polymorphisms are not associated with the risk of hepatitis B and hepatitis C virus infection.

Sá KS, Pires-Neto Ode S, Santana BB, Gomes ST, Amoras Eda S, Conde SR, Demachki S, Azevedo VN, Machado LF, Martins-Feitosa RN, Ishak Mde O, Ishak R, Vallinoto AC.

Rev Soc Bras Med Trop. 2015 Mar-Apr;48(2):136-42. doi: 10.1590/0037-8682-0008-2015.

16.

Genetic diversity, viraemic and aminotransferases levels in chronic infected hepatitis B patients from Cameroon.

Tufon KA, Meriki HD, Anong DN, Mbunkah HA, Nkuo-Akenji T.

BMC Res Notes. 2016 Feb 22;9:117. doi: 10.1186/s13104-016-1916-7.

17.

Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.

Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagano A, Ponticelli C, Locatelli F.

Am J Kidney Dis. 2001 Nov;38(5):1009-15.

PMID:
11684554
18.

Tumour necrosis factor-alpha, interleukin-10, interferon-gamma and vitamin D receptor gene polymorphisms in patients with chronic hepatitis delta.

Karatayli SC, Ulger ZE, Ergul AA, Keskin O, Karatayli E, Albayrak R, Ozkan M, Idilman R, Yalcin K, Bozkaya H, Uzunalimoğlu O, Yurdaydin C, Bozdayi AM.

J Viral Hepat. 2014 Apr;21(4):297-304. doi: 10.1111/jvh.12139. Epub 2013 Jul 22.

PMID:
24597698
19.

Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels.

Cheong JY, Kim DJ, Hwang SG, Yang JM, Kim YB, Park YN, Cho SW.

Liver Int. 2011 Oct;31(9):1352-8. doi: 10.1111/j.1478-3231.2011.02570.x. Epub 2011 Jun 23.

PMID:
21745311
20.

[Investigation of the relationship between serum nitric oxide levels, HBV-DNA and ALT levels in chronic hepatitis B patients].

Sener AG, Kirdar S, Serter M, Afşar I, Demir EM, Ceylan C, Aydin N.

Mikrobiyol Bul. 2009 Jan;43(1):83-9. Turkish.

PMID:
19334384

Supplemental Content

Support Center